Thromboxane-A synthase
Thromboxane-A synthase (TXAS) is an enzyme that plays a crucial role in the biosynthesis of Thromboxane A2 (TXA2), a potent vasoconstrictor and platelet aggregator. This enzyme catalyzes the conversion of Prostaglandin H2 (PGH2) to Thromboxane A2. Thromboxane A2 is involved in several physiological and pathological processes, including blood clotting, inflammation, and the pathogenesis of various cardiovascular diseases.
Function[edit | edit source]
Thromboxane-A synthase is a member of the cytochrome P450 superfamily of enzymes (specifically, CYP5A1). It is located primarily in platelets and macrophages, where it facilitates the production of TXA2 following the activation of these cells. TXA2 acts as a powerful vasoconstrictor and promotes platelet aggregation, playing a vital role in hemostasis and thrombosis. However, excessive production of TXA2 has been implicated in the development of cardiovascular diseases such as myocardial infarction, stroke, and atherosclerosis.
Clinical Significance[edit | edit source]
Given its role in promoting thrombosis and vasoconstriction, Thromboxane-A synthase is a target for therapeutic intervention in cardiovascular diseases. Inhibitors of TXAS, such as aspirin, are used to prevent platelet aggregation and reduce the risk of myocardial infarction and stroke. Aspirin acetylates the enzyme, irreversibly inhibiting its activity and thus decreasing the production of TXA2.
Research is ongoing to develop more selective and potent inhibitors of Thromboxane-A synthase as potential treatments for cardiovascular diseases and other conditions where TXA2 plays a detrimental role.
Genetics[edit | edit source]
The gene encoding Thromboxane-A synthase is located on human chromosome 7q34-q35. Mutations in this gene can affect the enzyme's function and have been studied in relation to their impact on disease susceptibility, particularly in the context of cardiovascular diseases.
See Also[edit | edit source]
References[edit | edit source]
This article is a Cardiovascular system stub. You can help WikiMD by expanding it!
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
